NO890681L - Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner. - Google Patents

Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner.

Info

Publication number
NO890681L
NO890681L NO89890681A NO890681A NO890681L NO 890681 L NO890681 L NO 890681L NO 89890681 A NO89890681 A NO 89890681A NO 890681 A NO890681 A NO 890681A NO 890681 L NO890681 L NO 890681L
Authority
NO
Norway
Prior art keywords
alkyl
preparation
aroyloxazolons
alkanoyl
procedure
Prior art date
Application number
NO89890681A
Other languages
English (en)
Norwegian (no)
Other versions
NO890681D0 (no
Inventor
Richard A Schnettler
Winton D Jones
Richard C Dage
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO890681D0 publication Critical patent/NO890681D0/no
Publication of NO890681L publication Critical patent/NO890681L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/38One oxygen atom attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO89890681A 1988-02-18 1989-02-17 Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner. NO890681L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/157,430 US4866182A (en) 1988-02-18 1988-02-18 Cardiotonic alkanoyl and aroyl oxazolones

Publications (2)

Publication Number Publication Date
NO890681D0 NO890681D0 (no) 1989-02-17
NO890681L true NO890681L (no) 1989-08-21

Family

ID=22563682

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890681A NO890681L (no) 1988-02-18 1989-02-17 Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner.

Country Status (19)

Country Link
US (1) US4866182A (zh)
EP (1) EP0329070B1 (zh)
JP (1) JP2811577B2 (zh)
KR (1) KR960014794B1 (zh)
CN (1) CN1022035C (zh)
AT (1) ATE99681T1 (zh)
AU (1) AU614029B2 (zh)
CA (1) CA1334201C (zh)
DE (1) DE68911944T2 (zh)
DK (1) DK74889A (zh)
ES (1) ES2061748T3 (zh)
FI (1) FI890694A (zh)
HU (1) HU206880B (zh)
IL (1) IL89302A (zh)
NO (1) NO890681L (zh)
NZ (1) NZ227977A (zh)
PH (1) PH26260A (zh)
PT (1) PT89749B (zh)
ZA (1) ZA891111B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5437491A (en) * 1994-04-07 1995-08-01 Illinois Tool Works Inc. Fuel door housing
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
CN102993075A (zh) * 2012-11-29 2013-03-27 江苏长青农化股份有限公司 硫脲类杀虫杀螨剂丁醚脲的合成工艺
NZ738563A (en) 2015-06-03 2019-09-27 Bristol Myers Squibb Co 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
US4303439A (en) * 1979-10-01 1981-12-01 Monsanto Company 2-Substituted-4-alkyl or trihaloalkyl-5-oxazolecarboxylic acids as safening agents
JPS59100977A (ja) * 1982-12-01 1984-06-11 Omron Tateisi Electronics Co 記録情報出力方法
DE3246957A1 (de) * 1982-12-18 1984-06-20 Varta Batterie Ag, 3000 Hannover Galvanisches element
EP0114263B1 (de) * 1982-12-18 1987-03-11 Hans Rinninger u. Sohn GmbH u. Co. Pflasterstein
US4623651A (en) * 1985-10-15 1986-11-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones
US4762849A (en) * 1985-10-15 1988-08-09 Merrell Dow Pharmaceuticals Inc. Cardiotonic alkanoylthiazolones
CA1266268C (en) * 1985-10-15 1990-02-27 CARDIOTONIC AROYLTHIAZOLONES
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4689353A (en) * 1986-02-21 1987-08-25 The Dow Chemical Company Hydroxy and amino-functional polyahls containing carbonate, urethane and/or urea moieties

Also Published As

Publication number Publication date
KR890012983A (ko) 1989-09-20
HU206880B (en) 1993-01-28
ES2061748T3 (es) 1994-12-16
PH26260A (en) 1992-04-01
PT89749B (pt) 1994-03-31
PT89749A (pt) 1989-10-04
CN1022035C (zh) 1993-09-08
AU614029B2 (en) 1991-08-15
ZA891111B (en) 1989-10-25
ATE99681T1 (de) 1994-01-15
DE68911944D1 (de) 1994-02-17
FI890694A (fi) 1989-08-19
CA1334201C (en) 1995-01-31
EP0329070A1 (en) 1989-08-23
NO890681D0 (no) 1989-02-17
IL89302A0 (en) 1989-09-10
US4866182A (en) 1989-09-12
JP2811577B2 (ja) 1998-10-15
NZ227977A (en) 1990-10-26
AU2990689A (en) 1989-08-24
IL89302A (en) 1993-02-21
CN1036761A (zh) 1989-11-01
DK74889A (da) 1989-08-19
JPH02149571A (ja) 1990-06-08
DE68911944T2 (de) 1994-05-19
HUT54148A (en) 1991-01-28
FI890694A0 (fi) 1989-02-14
KR960014794B1 (en) 1996-10-19
DK74889D0 (da) 1989-02-17
EP0329070B1 (en) 1994-01-05

Similar Documents

Publication Publication Date Title
DK5389A (da) Substituerede pyrroler, pyrazoler og triazoler, fremgangsmaader til deres fremstilling samt deres anvendelse som angiotensin ii-antagonister
ES2062403T3 (es) 5-((tetrazolil)-alquenil)-imidazoles sustituidos.
NO895086D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
AU1611192A (en) Fibrinogen receptor antagonists
ES2115163T3 (es) Procedimiento para inhibir la proliferacion de celulas de musculos lisos y la restinosis.
NO872863L (no) AnalogifremgangsmŸte for fremstilling av terapeutiske imidazoler som blokkerer angiotensin-ii-reseptorer.
ES2180580T3 (es) Compuestos de oxazolilo sustituidos para el tratamiento de la inflamacion.
NO895170D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 7-oksabicykloheptyl-substituerte heterocyklisk amid-prostaglandinanaloger.
NO890681L (no) Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner.
GR860707B (en) Herbicide and insecticide means based on pyrazol derivatives
NO168246C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
ES8601923A1 (es) Procedimiento para la obtencion de n-sulfonil-n'pirimidil- y -triacinil-ureas
EP0357201A3 (en) Pyridyl pyrimidinone derivatives with an insecticidal activity
SG48250A1 (en) 4-substituted dihydropyrido (4,3-d) pyrimidines as analgesics and topical antiinflammatory agents forthe treatment of skin disorders
NZ216334A (en) Spiro imidazolone derivatives and pharmaceutical composition
NZ515409A (en) 5-substituted arylpyrimidines
NO883776D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
AU8114387A (en) Use of 5-(substituted phenyl)-oxazolidinone derivatives for treatment of depression
AU555244B2 (en) Substituted alkanoylimidazol-2-one derivatives
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru
NO171639C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater
EP0337350A3 (en) Use of dimethylheptylphenyl butanoyl ethanolamine in treatment of hyperuricemia
JO1599B1 (en) Therapeutic agents
NO870499D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO882636L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksygenholdige heterocykliske forbindelser.